Transparency
Market Research Reports incorporated a definite business overview and
investigation inclines on “Perennial
Allergic Rhinitis Market”.
This report likewise incorporates more illumination about fundamental
review of the business including definitions, requisitions and
worldwide business sector industry structure. Rhinitis is an acute
disease of the nasal system. Rhinitis is the irritation and
inflammation of the internal lining and mucous membrane of the nose.
The rhinitis is one of the short term and environment related
disorders, which is identified by common symptoms, such as, runny
nose, stuffy nose and post-nasal drip.
Browse
Full Report with TOC:
http://www.transparencymarketresearch.com/perennial-allergic-rhinitis-market.html
Among
various types of rhinitis, allergic rhinitis is the most common
disease. Allergic rhinitis, as the name indicates, occurs due to
various allergy propelling factors, such as, pollen grains, dust,
mist, fog, and other airborne allergens. When these allergens are
inhaled by immune-sensitive person, it triggers the production of IgE
(immunoglobulin E antibody). IgE triggers the histamine secretion,
which leads to irritation and inflammation of mucous membrane.
Perennial allergic rhinitis is the most common and frequently
occurring type of allergic rhinitis.
The
major symptoms of the disease include itching, sneezing, rhinorrhea,
nasal obstruction and congestion. Sometimes, rhinitis may occur due
to chronic diseases, such as, asthma, eczema and depression. The
causes of the disease include pollens and airborne allergens of
various natural origin, such as, trees, weeds and grasses. The
disease is diagnosed by using Radio Allergo Sorbent Testing (RAST)
blood test, skin test (patch test), skin prick test, and allergen
sensitivity test.
The
market of perennial allergic rhinitis is segmented on the basis of
drugs classes used for the treatment, such as, steroids,
antihistamines, allergen immunotherapy formulations, decongestants,
and other complimentary treatments. Steroids class mainly includes
intranasal corticosteroids, prednisolone, beclometasone, and
triamcinolone acetonide. Whereas, antihistamines class include
citrizine, chlorphenamine, promethazine, acrivastine, loratadine and
others. Allergen immunotherapy formulations mainly include
desensitizing vaccines. Decongestants mainly include phenylephrine
hydrochloride and others. Other treatments include cromolyn
formulations (sodium cromoglycate as anti-inflammatory agent),
leukotriene receptor antagonists and others. Further, the market is
segmented on the basis of geography, such as North America, Europe,
Asia-Pacific and Rest of the World (RoW). The European region is the
most dominating market in the world, owing to large number of
perennial allergic rhinitis diagnosed patients. On the other hand,
Asia-Pacific and RoW regions are the most promising markets in
upcoming period, owing to rising awareness and treatment of disease
and rising prevalence of disorder, and growth of medical
infrastructure.
The
market of perennial allergic rhinitis is expected to show steady
growth during the forecast period 2014 – 2020. This growth is
driven by various factors, such as extensive R&D practices to
develop new and more effective products and formulations, rising
number of patients, changes in lifestyle and other environmental
conditions. These factors are coupled with rising awareness about the
disease and its diagnosis. According to World Allergy Organization
(WAO), the prevalence of allergic rhinitis varies from 1.4% to 40% in
various countries of the world. European and APAC countries are the
most prevalent to disease, due to frequently varying environmental
and climatic conditions. According to American College of Asthma,
Allergy and Immunology (ACAAI), in 2010, around 16.9 million adults
and 6.7 million children were diagnosed with hay fever. This high
prevalence of the disease is anticipated to propel the growth of the
market during the forecast period 2014 – 2020. Further, due to
extensive R&D practices, a number of new formulations for the
treatment of perennial allergic rhinitis are under pipeline studies.
For instance, formulations like S-555739, desloratadine, GMNL-32 and
many others are under pipeline studies and are expected to enter in
the market during upcoming 5-10 years.
Hence,
this fact is expected to fuel growth of the market. Major restraints
include ignorance towards the disease and side effects of the
therapy, which may limit the growth of the market to certain extent.
Some
of the major players operating in this market include Pfizer, Inc.,
Merck & Co., Inc., Teva Pharmaceutical Industries Ltd., and Hanmi
Pharmaceuticals, Inc. amongst others.
Read
More Reports on Pharmaceutical Markets:
http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html
This
research report analyzes this market depending on its market
segments, major geographies, and current market trends. Geographies
analyzed under this research report include
- North America
- Asia Pacific
- Europe
- Rest of the World
This
report provides comprehensive analysis of
- Market growth drivers
- Factors limiting market growth
- Current market trends
- Market structure
- Market projections for upcoming years
This
report is a complete study of current trends in the market, industry
growth drivers, and restraints. It provides market projections for
the coming years. It includes analysis of recent developments in
technology, Porter’s five force model analysis and detailed
profiles of top industry players. The report also includes a review
of micro and macro factors essential for the existing market players
and new entrants along with detailed value chain analysis.
Enquiry
before Buying @
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2936
About
Us
Transparency
Market Research is a market intelligence company providing global
business information reports and services. Our exclusive blend of
quantitative forecasting and trends analysis provides forward-looking
insight for thousands of decision makers.
Followed
LinkedIn
:-https://www.linkedin.com/today/post/article/20140808063513-349336221-perennial-allergic-rhinitis-market
Contact:
Transparency
Market Research
90
State Street,
Suite
700,
Albany
NY — 12207
United
States
Tel:
+1-518-618-1030
USA — Canada
Toll Free 866-552-3453
Browse
Market Research Blogs: